key: cord-0314946-726tcic3
authors: Divya, C. A.; Dhar, Sujan K; Shantaram, Manjula; Das, Manjula
title: Anti-diabetic effects of Holarrhena antidysentrica extracts: Results from a Longitudinal Meta-analysis
date: 2021-02-12
journal: bioRxiv
DOI: 10.1101/2021.02.11.430868
sha: 4818f1fb634c50f60c130aedfc0f324264f0dafb
doc_id: 314946
cord_uid: 726tcic3

Background Holarrhena antidysenterica (HA), a twining shrub belonging to the Apocynaceae family is found in tropical regions of Africa and over a large part of Asia including India, Philippines and Malayan Peninsula. In Indian traditional system of medicine, HA has been used to treat gastric ailments, for wound healing and also to improve glycaemic control. Glucose lowering activity of HA root, bark, seed, leaf and fruit extract in different parts of India as well as in Chinese traditional medicine is widely reported. Purpose In the meta-analysis reported in this article, we summarize glucose-lowering effects of HA extracts from different plant parts as reported in multiple studies involving animal models of diabetes. Our analysis helps to quantify the glucose-lowering effect of HA in comparison with standard diabetes drugs. The analysis also sheds light on differential efficacy levels of HA extracted from different plant parts. Study design The meta-analysis was carried out following PRISMA guidelines. Literature was searched to identify studies published between years 2011 to 2019 reporting glucose-lowering effects of HA extract on rodent models of diabetes. Methods Longitudinal meta-analysis was carried out on time-course data extracted from selected studies to calculate standardized mean change of glucose value from day 1 to days 7, 14 and 21 post-treatment by HA extract or standard anti-diabetic drug. Subgroup analysis was carried out for studies reporting effects of HA on leaf and seed extracts. Standardized mean difference in levels of cholesterol, triglycerides and serum total protein between treatment and control groups were also assessed. Results We shortlisted nine articles to be used for this meta-analysis. Summarized standardized mean changes of glucose value between day 1 and day 21 post-treatment indicated glucose-lowering effects of HA extracts to be marginally lower but comparable to that of standard anti-diabetic drugs like Glibenclamide or Sitagliptin. However, subgroup analysis revealed seed extracts of HA to be more potent than leaf extracts or even standard drugs. Effects of the extract on levels of cholesterol, triglyceride and serum total protein was also commensurate with its glucose-lowering property. Conclusions Our results, summarized over multiple studies, present a clear quantitative assessment of the anti-diabetic property of HA, in particular the seed extracts compared to standard anti-diabetic drugs. Further differential analysis of the seed extracts will be useful to arrive at a herbal formulation with superior anti-diabetic property and possibly lesser side effects than chemical entities.

effects of HA extract on rodent models of diabetes. 48

Longitudinal meta-analysis was carried out on time-course data extracted from selected 50 studies to calculate standardized mean change of glucose value from day 1 to days 7, 14 51

and 21 post-treatment by HA extract or standard anti-diabetic drug. Subgroup analysis 52 was carried out for studies reporting effects of HA on leaf and seed extracts. Standardized 53 mean difference in levels of cholesterol, triglycerides and serum total protein between 54 treatment and control groups were also assessed. 55

We shortlisted nine articles to be used for this meta-analysis. Summarized standardized 57 mean changes of glucose value between day 1 and day 21 post-treatment indicated 58 glucose-lowering effects of HA extracts to be marginally lower but comparable to that of 59 standard anti-diabetic drugs like Glibenclamide or Sitagliptin. However, subgroup 60 Introduction 70 Diabetes mellitus is a chronic and serious metabolic disorder primarily manifested with 71 a hyperglycaemic condition as body is not able to produce sufficient quantity of Insulin 72 hormone or is not able to utilize the produced hormone. Latest Diabetic Atlas of 73

International Diabetic Foundation estimates around 463 million adults (20-79 years) 74 living with diabetes worldwide which is an astounding proportion of 9.3% of global adult 75 population(1). China, India and USA currently top the list of number of people with 76 diabetes and are likely to retain their unenviable ranking in the next ten years. Mortalities 77 in adults due to diabetes in 2019 was estimated as high as 4.2 million that is nearly twice 78 the 2.11 million deaths recorded due to COVID-19 till date(2). 79

Several classes of non-insulin pharmacological agents including sulfonylureas, 80 biguanides, thiazolidinediones, alpha-glucosidase inhibitors, dipeptidyl peptidase IV 81 inhibitors are currently used in clinic to improve glycaemic control. However, 82 undesirable side effects of many of these drugs often limit their use. On the other hand, 83 natural product-based anti-diabetics especially medicinal plants and herbal formulations 84 are very popular in many geographies due to their easy access, lesser cost and lesser side 85 effects. Several medicinal plants from middle-east Asia, China, south-east Asia including 86 India, Malaysia, Bangladesh, parts of Africa and Turkey have been documented in 87 literature for their use as anti-diabetics(3). In particular India has a large repertoire of 88 medicinal plants many of which have been used in traditional clinical practice to achieve 89 glycaemic control(4,5). Herbal formulations from these medicinal plants (6) and 90 phytocompounds derived from them (7) Ayurveda, HA is suggested for obesity, asthma, bronchopneumonia, hepatosplenomegaly, 98 rheumatism(9) diabetes, cancer and even for wound healing(10). It is also used as an 99

anti-oxidant and anti-depressant(11). 100 HA is studied extensively for treatment of metabolic diseases where the seed extract has 101 shown alpha-glucosidase activity in in vitro assay(12). Ethanolic and methanolic extracts 102 of bark from HA shown inhibitory effect of glycemia(13). Treatment of Streptozotocin 103 (STZ) induced diabetic rats or mice by extracts of HA from different plant parts including 104 seed, leaf and bark have resulted in lowering of blood glucose over a period of 7 to 21 105 days post-treatment(14-18) 106 Though many studies have indicated possible glucose-lowering and anti-diabetic activity 107 of HA extract, its usefulness in comparison with known anti-diabetic compounds is not 108 well established. Further, usage of various plant parts such as leaf and seed extracted with 109 different solvent adds heterogeneity and ambiguity in results. In this article, we attempt 110 to answer some of these questions by carrying out a careful meta-analysis of data 111 collected from literature on observed anti-diabetic effects of HA extracts in animal 112 models of diabetes in comparison with effects caused by standard anti-diabetic drugs like 113 Glibenclamide or Sitagliptin. With a number of studies reported in literature to assess the 114 anti-diabetic effects of HA extracts, to our knowledge this is the only meta-analysis study 115 aiming to compare summary effects of HA extract to the effect caused by standard drugs. 116 One article (22) did not provide the data in tabular form, for which, data was extracted 133 from the graphs using WebPlotDigitizer online tool (23). For blood glucose time profile, 134 the start time was normalized to the day of administration of extract or reference drug. 135

Choice of appropriate statistics for longitudinal meta-analysis is crucial. To measure the 137 effect in change in blood glucose levels within the same group of animals we use a random 138 effects model on the standardized mean change (SMC) with raw score 139 standardization(24), between start of the treatment (day 1) and days 7, 14 and 21 post-140 treatment separately for animals treated with HA extract or reference drug. For other 141 parameters, such as total cholesterol, triglycerides or serum protein measured at the end 142 of the study period, we use the standardized mean difference (SMD) of measured 143 parameter between treatment and diabetes control groups with Hedges' correction for 144 positive bias. All calculations were carried out using the Metafor library (25) on R 145 statistical software platform. Meta-regression of SMC of blood glucose between start and 146 day 21 of treatment was carried out using mixed-effects model with dose of the extract 147 (in mg/kg) and other categorical variables such as plant part and solvent used for 148 extraction as moderators. 149

The search yielded a total of 104 "hits" which were screened manually to select 9 articles 152 containing levels of blood glucose and other parameters measured in animal models of 153 diabetes ( Fig. 1 ). All studies employed STZ-induced rodent models as the experimental 154 platform. 155 Different plant parts of H. antidysenterica such as leaf (18,22) and seed (15,16,20,26-29) 156 extracted with different solvents such as Ethanol, Ethyl acetate, Water, Petroleum ether 157 and Methanol were used for treatment of the animals. Leaf or seed were powdered after 158 air drying in shade and were extracted in a Soxhlet apparatus, employing respective 159 solvents. Concentrated extract was air dried at room temperature or under reduced 160 pressure and stored in air tight container in 2-8°C for use in experiments. 161 Some studies also compared glucose-lowering effects of standard drugs such as 162 Glibenclamide (16, 18, 20, [26] [27] [28] or Sitagliptin (22) along with HA on same experimental 163 platform. Diabetes was induced by single intraperitoneal injection of STZ 50 mg/kg. 164 Development of diabetes was confirmed by fasting blood glucose estimation 72 h post-165 STZ injection, wherein animals were fasted overnight before blood collection. Animals 166 with fasting blood glucose level above 200 mg/dL at 72 h after STZ injection were 167 considered diabetic and were included in experiments. Animals were randomly divided 168 into groups of 6 each and assigned for treatment. Plant extract was administered orally 169 every day in the dose range 100 -600 mg/kg along with the reference drug at working 170 concentration from the day of induction of diabetes. Fasting blood glucose was measured 171 on days 1, 7, 14, 21 and 28 from start of the treatment. 172

Apart from serum glucose, most studies also reported values of other parameters 173 (Table 1 ) out of which only three parameters -serum cholesterol, triglyceride and total 174 protein were selected for meta-analysis since their values were reported in three or more 175 studies. 176

From results of the studies, it is seen that administration of HA extract has glucose-178 lowering effect over days 7 -21 (Fig. 2) . Results of longitudinal meta-analysis ( Table 2 ) 179 reveal that the effect estimated as SMC (difference with day 1) increases progressively 180 from day 7 to day 21 for both HA extract as well as reference drug. On day 21, the effect 181 size of reference drug (12.93, 95% CI: 6.44, 19.42) is higher than the effect produced by 182 HA extract (9.53, 95% CI: 4.35, 14.70) (Fig. 3) . However, results for HA extract showed 183 higher degree of heterogeneity (I 2 = 98.2%) compared to reference drug (87.3%) 184 indicating possible variations in the effect size of HA extract due to dose, plant part or 185 extraction solvent used. 186

Meta-regression of the serum glucose SMC on day 21 for HA extract with dose as 188 moderator did not show any statistically significant dependence of the SMC with dose of 189 extract administered ( Supplementary Fig. 1 ). To estimate variations due to plant parts, 190

we performed the meta-analysis for the two subgroups, HA leaf and seed extracts used in 191 studies. This subgroup analysis results (Fig. 4) Hence, we did not perform a separate subgroup analysis on the solvent as the results will 197 not be different than results of plant part subgroups. Nevertheless, it is important to note 198 that the seed extracts appear to be the most potent anti-diabetic fraction with a higher 199 glucose lowering effect than the observed effects of Glibenclamide or Sitagliptin. 200

Meta-analysis of the other markers shows both HA extract and reference drugs reduce 202 total cholesterol (Supplementary Fig. 2 ) and triglycerides ( Supplementary Fig. 3) in 203 serum on day 21 compared to the corresponding value in control diabetic animals who 204 did not receive any treatment. SMD value for reference drugs is higher than that of HA 205 extract (Table 3) . However, for serum total protein, the reference drugs do not show any 206 statistically significant summary effect (p > 0.1) whereas with HA extract a marginally 207 significant effect (p = 0.051) is observed (Supplementary Fig. 4) . More detailed studies with differential identification of compounds between seed and 254 leaf extracts will perhaps unlock the true antidiabetic potential of HA as a herbal 255 formulation. 256

This meta-analysis conclusively summarizes the anti-diabetic effect of HA extract seen in 258 rodent diabetic models across 9 different studies. Ethanol extracts of HA seeds appear to 259 have more potent glucose-lowering ability than reference drugs like Glibenclamide and 260

Sitagliptin. Further, the HA extracts also lowered serum cholesterol and triglycerides and 261 restored total serum proteins in diabetic animals. Further studies on HA extracts can lead 262 to novel herbal formulations with anti-diabetic effects comparable to chemical 263 compounds. 264 

281 2. World Health Organization. COVID-19 Weekly Epidemiological Update -27

Diabetic Mice. J Evidence-Based Integr Med

Beneficial dose-independent influence of Camellia sinensis 375 supplementation on lipid profile, glycemia, and insulin resistance in an NaCl-376 induced hypertensive rat model

Hypoglycemic Effect of Lippia javanica in 378

Alloxan Induced Diabetic Mice

Antihyperglycemic and hypolipidemic effects of α,β-amyrin, a triterpenoid mixture 381 from Protium heptaphyllum in mice

Anti-diabetic effect of 383 betulinic acid on streptozotocin-nicotinamide induced diabetic male mouse model

Acid: A Promising Use of a Traditional Pharmacological Agent

Antidiabetic effect of 389 quercetin: A systematic review and meta-analysis of animal studies

Holarrhena antidysenterica Seed) on Inpatient Uncomplicated Severe 393

Hyperglycaemia: A Case Study

Validations of Tribal Claims On Vanda 395

Vitex Negundo L. And Holarrhena

Antibacterial efficacy of five medicinal plants against multidrug-399 resistant enteropathogenic bacteria infecting under-5 hospitalized children